Mask With Myoinositol/Trehalose Aids Adult Female Acne

This article originally appeared here.
Share this content:
Mask With Myoinositol/Trehalose Aids Adult Female Acne
Mask With Myoinositol/Trehalose Aids Adult Female Acne

MONDAY, April 10, 2017 (HealthDay News) -- A ready-to-use peel-off facial mask containing myoinositol and trehalose-loaded liposomes results in clinically detectable improvements in adult female acne (AFA), according to a study published online March 25 in the Journal of Cosmetic Dermatology.

Gabriella Fabbrocini, M.D., from the University of Naples in Italy, and colleagues evaluated whether a ready-to-use peel-off facial mask containing myoinositol (an androgen inhibitor) and trehalose-loaded liposomes (as activators of cutaneous autophagy) applied overnight every other day for 60 days improved AFA in 40 patients.

The researchers found that the mean counts of comedones, papules, pustules, and nodular lesions decreased significantly (all P < 0.001). The mean Sebutape score was reduced significantly (P < 0.001), as was the mean Global Acne Grading System scale score from baseline to after treatment (P < 0.001). Skin biopsy supernatants showed a significant decrease in testosterone and dehydroepiandrosterone sulfate and a significant increase in beclin-1 levels (P < 0.001).

"A ready-to-use peel-off facial mask containing myoinositol and trehalose-loaded liposomes improved the cosmetic appearance of AFA by reducing cutaneous androgen content and promoting skin autophagy," the authors write.

One author disclosed financial ties to Biodue, which provided the facial masks and partly funded the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »